The latter may be achieved by modulating the activities of specific 5-HT receptors that trigger the activation of fibrogenic signal transduction.
Recent studies have demonstrated that RvE1, RvD1, RvD2, NPD1, and maresin 1 potently suppress somatic inflammatory pain, to some extent by modulating the activities of TRPV1 and TRPA1 and by regulating TRPV1 and TRPA1 activation-elicited synaptic plasticity [ 28, 33, 34].
As the main mediators of cell-ECM interactions they are key players in early development [ 2] functioning in gastrulation by rapid modulation of their own adhesion between low and high affinity states and by modulating the activities of adhesion molecules (e.g. cadherins) in cell layers undergoing convergence and extension [ 3].
It is likely that vascular endothelial growth factor, pro-inflammatory cytokines, advanced glycation end products, and adhesion molecules that also play a role in diabetic retinopathy may do so by modulating the activities of aldose reductase and nitric oxide synthase.
Indeed, several groups have now demonstrated that ISG15 inhibit polyubiquitylation by modulating the activities of selected ubiquitin E2 and E3 ligases [26], [27], [30] [32].
Moreover this can be achieved by modulating the activities of a small number of specific growth factors either through their addition to the medium or their pharmacological inhibition (for summary see Figure 5).
Previous studies have suggested that EGCG produces anti-cancer effect by modulating the activity of mitogen-activated protein kinases (MAPKs), IGF/IGF-1 receptor, Akt, NF-κB, and CDKs [ 4- 7].
Through these interactions, Src controls cell growth and survival by modulating the activity of such intracellular effectors as PI3K/Akt and signal transducer and activator of transcription 3 (STAT3) [ 11].
A recent report shows that β-catenin achieves some of these effects by modulating the activity of Tcf3, and that this effect does not require its transcriptional activation domain.
